Esketamine Nasal Spray is a medication used together with an antidepressant taken by mouth, for treating the patients of depression, who had taken atleast 2 antidepressants treatment that did not work. Esketamine nasal spray is also used as a general anaesthetics.
Esketamine Nasal Spray Market contains market size and forecasts of Esketamine Nasal Spray in global, including the following market information:
- Global Esketamine Nasal Spray Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Esketamine Nasal Spray Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Esketamine Nasal Spray companies in 2021 (%)
The global Esketamine Nasal Spray market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
General Anaesthetics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Esketamine Nasal Spray include Pfizer Inc, Merck&Co, Medkoo, Endo International Plc and Johnson & Johnson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Esketamine Nasal Spray manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Esketamine Nasal Spray Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Esketamine Nasal Spray Market Segment Percentages, by Type, 2021 (%)
- General Anaesthetics
- Treatment-Resistant Depression
- Others
Global Esketamine Nasal Spray Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Esketamine Nasal Spray Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
Global Esketamine Nasal Spray Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Esketamine Nasal Spray Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Esketamine Nasal Spray revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Esketamine Nasal Spray revenues share in global market, 2021 (%)
- Key companies Esketamine Nasal Spray sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Esketamine Nasal Spray sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer Inc
- Merck&Co
- Medkoo
- Endo International Plc
- Johnson & Johnson
Industry Market Size
